Actively Recruiting

Phase Not Applicable
Age: 30Years - 75Years
All Genders
NCT06416722

Telerehabilitation Dual-Task Training for Parkinson's: A Multidimensional Evaluation

Led by Fenerbahce University · Updated on 2025-06-27

30

Participants Needed

1

Research Sites

65 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

In this clinical study, the aim is to assess the effectiveness of telerehabilitation-based dual-task training in improving balance and gait function among individuals diagnosed with Parkinson's Disease. Parkinson's Disease is characterized by motor symptoms such as tremors and slowness of movement, as well as cognitive impairments. While medical treatments help manage symptoms, exercise programs are vital for enhancing physical and cognitive functions. Dual-task training involves combining motor and cognitive activities to enhance gait and balance control, and recent studies have shown its effectiveness in Parkinson's Disease rehabilitation. However, there's limited research on delivering dual-task training through telerehabilitation and determining the optimal content for maximum benefits. This project involves 30 Parkinson's Disease patients who will be randomly assigned to three groups receiving different dual-task exercise programs via telerehabilitation. Each program focuses on combining balance and functional exercises with either cognitive or motor secondary activities. The exercises will be performed three times a week for four weeks under the guidance of a physiotherapist via Zoom. Before and after the intervention, participants will be evaluated for feasibility, gait, balance, cognition, and activity levels. Researchers of this study hypothesize that telerehabilitation-based dual-task training will significantly improve balance and gait function in Parkinson's Disease patients, offering a convenient and effective treatment option to enhance their quality of life.

CONDITIONS

Official Title

Telerehabilitation Dual-Task Training for Parkinson's: A Multidimensional Evaluation

Who Can Participate

Age: 30Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with idiopathic Parkinson's Disease
  • Stage 1-3 on the Hoehn-Yahr scale
  • Minimum score of 21 on the Montreal Cognitive Assessment Scale
  • Stable drug treatment for at least 1 month
  • Currently in the "On" period of medication
  • Ability to walk independently on level ground (Functional Ambulation Classification 3 or above)
Not Eligible

You will not qualify if you...

  • Serious hearing or vision problems
  • Other neurological, cardiovascular, or orthopedic disorders that prevent walking
  • Any other neurological disorder such as dementia or cerebrovascular disease
  • Less than 5 years of education
  • Vascular lower extremity pathologies
  • No internet access via smartphone or computer

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Bakırköy Prof. Dr. Mazhar Osman Ruh Sağlığı ve Sinir Hastalıkları Eğitim ve Araştırma Hastanesi

Istanbul, Bakırköy, Turkey (Türkiye)

Actively Recruiting

Loading map...

Research Team

E

Ezgi Gul, MSc, Pt, Research Assistant

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here